Ignite Creation Date:
2024-05-06 @ 1:33 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01837511
Status:
COMPLETED
Last Update Posted:
2013-04-23
First Post:
2013-04-05
Brief Title:
Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I II and III Non-Small Cell Lung CancerNSCLC in Asiatic Patients
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Analysis of the Incidence of Expression of Tumor Antigens MAGE-A3 MAGE-C2 NY-ESO-1 LAGE-1 WT1 and PRAME in Pathologically Proven Stage I II and III Non-Small Cell Lung Cancer in Asiatic Patients
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to investigate the expression of Melanoma-associated antigen 3 MAGE-A3 Melanoma-associated antigen C2 MAGE-C2 New York esophageal squamous cell carcinoma 1 NY-ESO-1 L antigen family member 1 LAGE-1 Wilms tumor gene WT1 and PRAME PReferentially expressed Antigen of MElanoma tumor antigens in a large number of pathologically proven stage I II and III NSCLC samples of Asiatic patients
Detailed Description:
This study will be based upon the analysis of samples and patient-related data already available at the various investigation sites There will be no study treatment and no study-specific procedure carried out on the patients
Clinical data collected will include patient demographics age gender Tumor Node Metastasis staging system TNM stage histopathologic description and the patient smoker status Strict anonymity of patient data will be maintained
This retrospective study is based upon the analysis of archived formalin-fixed paraffin-embedded tissue samples and patient-related data already available at the investigational site
Clinical data collected will include patient demographics age gender Tumor Node Metastasis staging system TNM stage histopathologic description and the patient smoker status Strict anonymity of patient data will be maintained
This retrospective study is based upon the analysis of archived formalin-fixed paraffin-embedded tissue samples and patient-related data already available at the investigational site
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None